Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on August 13, 2026

Tempest Reports Second Quarter 2026 Financial Results and Provides Business Update
Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates
Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results
Cadrenal Therapeutics Reports Second Quarter 2026 Financial Results; Provides a Corporate Update on the Cardiac Acute Critical Care Franchise and the Strategic Partnering Process
Serina Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of AKTX-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform
Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey
Elutia Secures Up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results
Celcuity Inc. Reports Release of Second Quarter 2026 Financial Results and Provides Corporate Update
Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development Update
Equillium Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
4DMT Reports Second Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update
Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update
Elutia Secures $15 Million Loan Financing from Avenue Capital Group to Fund NXT-41x Launch in $1.5 Billion Plastic and Reconstructive Surgery Market
PetMeds® Announces First Quarter Financial Results
SRX Global Inc. Announces Fiscal Third Quarter 2026 Financial Results
Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Asia Healthcare Industry Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.